NeuroSense Therapeutics Ltd. (NRSN) NASDAQ
0.83
-0.0005(-0.06%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 19.6M |
| Enterprise Value | 19.6M |
| P/E Ratio | -3.25 |
| PEG Ratio | 0.83 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -13.56 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -6.33 |
| Return On Equity | 1,736 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -11.07M |
| Net Income | -11.13M |
| Diluted EPS | -0.44 |
Balance Sheet
| Total Cash | 166,000 |
| Total Cash/Share | 0.01 |
| Total Debt | 170,000 |
| Total Debt/Equity | -0.11 |
| Current Ratio | 0.31 |
| Book Value Per Share | -0.06 |
Price History
| 52-Week Change | -33.93 |
| 52-Week High | 2.6 |
| 52-Week Low | 0.63 |
| Moving Average 50 Days | 0.79 |
| Moving Average 200 Days | 1.01 |
Statistics
| Average Volume | 164,396 |
| Shares Outstanding | 24.67M |
| % Held by Institutions | 1.36 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
